Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VectorPoint Ventures is a private, purpose-driven impact venture capital firm and advisory practice focused on seed through early growth-stage companies. The firm invests across life sciences, healthcare, and clean technology, with a geographic emphasis on the greater Northwestern United States and broader North America. VectorPoint also operates through VectorPoint Impact Partners L.P. (VIP), a fund designed to back companies addressing major societal challenges while seeking financial returns. Rather than developing its own therapeutics, the firm functions as an investor and strategic advisor to emerging companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VectorPoint Ventures.